Anand Rajpara is a Dermatology physician affiliated with University of Missouri–Kansas City. OpenAlex indexes 148 publications with 515 citations (h-index 11).
Overview
Scholarship
indexed output and impact (OpenAlex)Distinct works indexed by OpenAlex, matched via ORCID.
Total citations across indexed works.
Hirsch index, productivity × impact (OpenAlex).
Clinical & industry
trials, payments and federal fundingContact
The practice address and phone this provider lists in the federal NPPES (CMS) registry.
Practice address
19000 E. Eastland Court
Independence, MO 64055
Telephone
816-404-2900Provider last certified this registry record 15 Aug 2022.
Industry payments
11 companies reported payments to CMS in program years 2021 onward. These are public disclosures, not judgments. The latest:
- UCB, Inc.Program year20241 payment
- Verrica Pharmaceuticals Inc.Program year20241 payment
- ABBVIE INC.Program year202210 payments
Payment records matched to this physician's NPI in CMS Open Payments, program years 2021 onward.
Medicare prescribing footprint (2024)
The drugs this prescriber writes for Medicare patients, grouped by drug class and therapeutic area. Every percentage is a share of their total prescribing, so you can see what they prescribe most. These are proportions, not patient counts or dollar amounts. No condition is inferred: the claims record what was prescribed, never why.
Sensory organs
30.3%Corticosteroid30.3%Clobetasol Propionate50%Hydrocortisone36%Betamethasone Dipropionate9%Betamethasone Valerate6%Part D<11 patientsDermatology
27.7%Corticosteroid14.4%Triamcinolone Acetonide100%Part D≥77 patientsInterleukin-4 Receptor alpha Antagonist13.2%Dupixent Pen100%Part D≥18 patientsAnti-infectives
18.2%Azole Antifungal12.6%Ketoconazole100%Part D≥55 patientsLincosamide Antibacterial2.3%Clindamycin Phosphate100%Part D≥17 patients+ 2 more classes in this area
Drug classes come from the WHO ATC and U.S. National Library of Medicine (RxClass) classifications; prescribing counts come from the CMS Medicare Part D Prescribers file. Each drug is counted once, under its primary class. Medicare fee-for-service only, so no Medicare Advantage, commercial, or pediatric prescribing is included. CMS publishes this data about 17 months after the fact.
Publications
Matched to this physician's OpenAlex author record; most-cited works shown first.
- A Multi-Site Survey Study of Patient Satisfaction with Teledermatology
Kansas Journal of Medicine
2022
Similar KOLs
Other experts from the same institution or the same specialty.
John Spertus, MD
University of Missouri–Kansas City
Barry Rutherford, MD
University of Missouri–Kansas City
Lamont Weide, MD, PhD, FACE
University of Missouri–Kansas City
Jill Moormeier, MD
University of Missouri–Kansas City
A basic profile from our physician directory: identity and practice contact from the federal NPPES registry, research from OpenAlex, trials from ClinicalTrials.gov, payments from CMS Open Payments — shown itemized where we have matched records, as a count where we only have a total. This person hasn't been through our full identity-adjudication pipeline yet, so funding, congress activity and public presence aren't shown. Absence of a section means “not yet looked,” never “none found.”